| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |